Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Multiple New Multi-Commodity Targets next post Excellent Gold Intersections Verified at Kiimala Project You may also like Joe Cavatoni: Gold’s Key Driver Now, Catalyst for... July 24, 2025 Coelacanth Energy June 21, 2025 Horizon Minerals August 22, 2025 Top 5 Canadian Mining Stocks This Week: Avanti... July 12, 2025 Stallion Uranium to Resume Trading on the TSX-V and... July 5, 2025 Seabed Mining Heats Up as Lockheed Martin Courts... July 16, 2025 Horn Island Mining Lease Application Registered August 15, 2025 3 Key Themes from Fastmarkets’ 2025 Lithium Supply... July 3, 2025 Juggernaut Closes $1,100,000 from Institutions and Accredited Investors July 9, 2025 xU3O8 (uranium.io): Pioneering Physical Uranium Ownership Powered by... May 2, 2025